Principal Financial Group’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$968K Buy
+55,446
New +$968K ﹤0.01% 1892
2024
Q3
Sell
-10,230
Closed -$87.1K 2397
2024
Q2
$87.1K Buy
+10,230
New +$87.1K ﹤0.01% 2233